Detail page

Knowledge Web

Person

Wolfgang Janni

Arzt

Name	Wolfgang Janni
Place	München (Wirkungsort) Deutschland
Gender	männlich
Academic degree	Prof. Dr. med.
Profession	Arzt (characteristic profession) Gynäkologe
Variant	W. Janni
Related	Frauenklinik (Düsseldorf) Universitätsklinikum Ulm. Klinik für Frauenheilkunde und Geburtshilfe Königliche Universitäts-Frauenklinik (München)
Record type	Person
GND-Identifier	135832640
Record ID	135832640
Involved in show all Feasibility of targeted therapies in the adjuvant setting of early breast cancer in men: real-world data from a population-based registry Novel Antibody-Drug-Conjugates in Routine Clinical Practice for the Treatment of Metastatic Breast Cancer: Adherence, Efficacy and Tolerability – Real-World Data from German Breast Centers Update Breast Cancer 2024 Part 1 – Expert Opinion on Advanced Breast Cancer Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2024 Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024 ESR1 Liquid Biopsy im metastasierten Mammakarzinom bei endokriner Resistenz Facharztprüfung Gynäkologie und Geburtshilfe : in Fällen, Fragen und Antworten Facharztprüfung Gynäkologie und Geburtshilfe : in Fällen, Fragen und Antworten Feasibility of targeted therapies in the adjuvant setting of early breast cancer in men: real-world data from a population-based registry Novel antibody-drug-conjugates in routine clinical practice for the treatment of metastatic breast cancer: adherence, efficacy and tolerability - real-world data from German breast centers = Neue Antikörper-Wirkstoff-Konjugate in der klinischen Praxis zur Behandlung von metastatischem Brustkrebs: Therapieadhärenz, Wirksamkeit und Verträglichkeit - Real-World-Daten aus deutschen Krebszentren The efficacy of sacituzumab govitecan and trastuzumab deruxtecan on stable and active brain metastases in metastatic breast cancer patients—a multicenter real-world analysis Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients Update breast cancer 2024 part 1 - expert opinion on advanced breast cancer Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer – Controversies and Standards in Healthcare Insights from ASCO 2023 Systemic therapy of premenopausal patients with early stage hormone receptor-positive, HER2-negative breast cancer – controversies and standards in healthcare Systemic therapy of premenopausal patients with early stage hormone receptor-positive, HER2-negative breast cancer: controversies and standards in healthcare The clinical relevance of the NATALEE study: application of the NATALEE criteria to a real-world cohort from two large German breast cancer centers Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers Practice-Changing Perspectives regarding Systemic Therapy in Early Breast Cancer: Opinions of German Experts regarding the 17th St. Gallen International Consensus Conference Ribociclib : verlängertes Gesamtüberleben bei Patientinnen mit lokal fortgeschrittenem oder metastasiertem HR+/HER2- Mammakrzinom Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2021 AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer : update 2021 Facharztwissen Gynäkologie Facharztwissen Gynäkologie Ginekologia, diagnostyka różnicowa i terapia : decyduj mądrze - lecz dobrze = Gynäkologie Differenzialdiagnostik und Differenzialtherapie Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients Update breast cancer 2020 part 5: moving therapies from advanced to early breast cancer patients Update Breast Cancer 2020 Part 2 – Advanced Breast Cancer: New Treatments and Implementation of Therapies with Companion Diagnostics AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer: update 2020 AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2020 Facharztprüfung Gynäkologie und Geburtshilfe : in Fällen, Fragen und Antworten Facharztprüfung Gynäkologie und Geburtshilfe : in Fällen, Fragen und Antworten Facharztwissen Gynäkologie Gynäkologie Differenzialdiagnostik und Differenzialtherapie : klug entscheiden - gut behandeln Does the number of removed axillary lymphnodes in high risk breast cancer patients influence the survival? Update Breast Cancer 2019 Part 2 – Implementation of Novel Diagnostics and Therapeutics in Advanced Breast Cancer Patients in Clinical Practice Update breast cancer 2019 part 2 – implementation of novel diagnostics and therapeutics in advanced breast cancer patients in clinical practice Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study Im Mittelpunkt Leben : wieder stark werden nach Brustkrebs Im Mittelpunkt Leben : Wieder stark werden nach Brustkrebs Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus : Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017) AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2017 Facharztwissen Gynäkologie Facharztwissen Gynäkologie Weiterbildung Gynäkologie und Geburtshilfe : CME-Beiträge aus: Der Gynäkologe Juli 2014-Dezember 2015 Weiterbildung Gynäkologie und Geburtshilfe : CME-Beiträge aus: Der Gynäkologie Juli 2014 – Dezember 2015 Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study Erkrankungen der Vulva Erkrankungen der Vulva Erkrankungen der Vulva Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study Interest in Integrative Medicine Among Postmenopausal Hormone Receptor – Positive Breast Cancer Patients in the EvAluate-TM Study 14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts 14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts Weiterbildung Gynäkologie und Geburtshilfe : CME-Beiträge aus: Der Gynäkologe Januar 2013 - Juni 2014 Fortgeschrittenes HR+, HER2-negatives Mammakarzinom in der Postmenopause : aktueller Stand der Therapie Follow-Up after Breast Cancer Diagnosis

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Wolfgang Janni

Feasibility of targeted therapies in the adjuvant setting of early breast cancer in men: real-world data from a population-based registry

Novel Antibody-Drug-Conjugates in Routine Clinical Practice for the Treatment of Metastatic Breast Cancer: Adherence, Efficacy and Tolerability – Real-World Data from German Breast Centers

Update Breast Cancer 2024 Part 1 – Expert Opinion on Advanced Breast Cancer

Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2024

Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024

ESR1 Liquid Biopsy im metastasierten Mammakarzinom bei endokriner Resistenz

Facharztprüfung Gynäkologie und Geburtshilfe : in Fällen, Fragen und Antworten

Facharztprüfung Gynäkologie und Geburtshilfe : in Fällen, Fragen und Antworten

Feasibility of targeted therapies in the adjuvant setting of early breast cancer in men: real-world data from a population-based registry

The efficacy of sacituzumab govitecan and trastuzumab deruxtecan on stable and active brain metastases in metastatic breast cancer patients—a multicenter real-world analysis

Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients

Update breast cancer 2024 part 1 - expert opinion on advanced breast cancer

Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer – Controversies and Standards in Healthcare

Insights from ASCO 2023

Systemic therapy of premenopausal patients with early stage hormone receptor-positive, HER2-negative breast cancer – controversies and standards in healthcare

Systemic therapy of premenopausal patients with early stage hormone receptor-positive, HER2-negative breast cancer: controversies and standards in healthcare

The clinical relevance of the NATALEE study: application of the NATALEE criteria to a real-world cohort from two large German breast cancer centers

Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers

Practice-Changing Perspectives regarding Systemic Therapy in Early Breast Cancer: Opinions of German Experts regarding the 17th St. Gallen International Consensus Conference

Ribociclib : verlängertes Gesamtüberleben bei Patientinnen mit lokal fortgeschrittenem oder metastasiertem HR+/HER2- Mammakrzinom

Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2021

AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer : update 2021

Facharztwissen Gynäkologie

Facharztwissen Gynäkologie

Ginekologia, diagnostyka różnicowa i terapia : decyduj mądrze - lecz dobrze = Gynäkologie Differenzialdiagnostik und Differenzialtherapie

Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients

Update breast cancer 2020 part 5: moving therapies from advanced to early breast cancer patients

Update Breast Cancer 2020 Part 2 – Advanced Breast Cancer: New Treatments and Implementation of Therapies with Companion Diagnostics

AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer: update 2020

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2020

Facharztprüfung Gynäkologie und Geburtshilfe : in Fällen, Fragen und Antworten

Facharztprüfung Gynäkologie und Geburtshilfe : in Fällen, Fragen und Antworten

Facharztwissen Gynäkologie

Gynäkologie Differenzialdiagnostik und Differenzialtherapie : klug entscheiden - gut behandeln

Does the number of removed axillary lymphnodes in high risk breast cancer patients influence the survival?

Update Breast Cancer 2019 Part 2 – Implementation of Novel Diagnostics and Therapeutics in Advanced Breast Cancer Patients in Clinical Practice

Update breast cancer 2019 part 2 – implementation of novel diagnostics and therapeutics in advanced breast cancer patients in clinical practice

Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study

Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study

Im Mittelpunkt Leben : wieder stark werden nach Brustkrebs

Im Mittelpunkt Leben : Wieder stark werden nach Brustkrebs

Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus : Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017)

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2017

Facharztwissen Gynäkologie

Facharztwissen Gynäkologie

Weiterbildung Gynäkologie und Geburtshilfe : CME-Beiträge aus: Der Gynäkologe Juli 2014-Dezember 2015

Weiterbildung Gynäkologie und Geburtshilfe : CME-Beiträge aus: Der Gynäkologie Juli 2014 – Dezember 2015

Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study

Erkrankungen der Vulva

Erkrankungen der Vulva

Erkrankungen der Vulva

Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study

Interest in Integrative Medicine Among Postmenopausal Hormone Receptor – Positive Breast Cancer Patients in the EvAluate-TM Study

14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts

14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts

Weiterbildung Gynäkologie und Geburtshilfe : CME-Beiträge aus: Der Gynäkologe Januar 2013 - Juni 2014

Fortgeschrittenes HR+, HER2-negatives Mammakarzinom in der Postmenopause : aktueller Stand der Therapie

Follow-Up after Breast Cancer Diagnosis